Exploring MAP2K3 as a prognostic biomarker and potential immunotherapy target in glioma treatment

Overview of attention for article published in Frontiers in Neurology, June 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 16 followers.

Leverage MAP2K3 gene for personalized glioma treatment with immunotherapy targeting immune cell infiltration. #GliomaCarePotential https://t.co/Ilx5P7Ta8q | Follow @biomedhack for #biohacking news to help you live healthier and longer. https://t.co/JPsWyLn

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.